G-Therapeutics has raised € 36 million to develop its novel neuro-stimulation therapy for people with spinal cord injuries (SCI). G-Therapeutics is a spin-off from École Polytechnique Fédérale de Lausanne (EPFL), with offices in Eindhoven and Lausanne. Sjaak Deckers, founder and CEO of the company, is well known from his former business Sapiens, that was taken over by Medtronic.

Get full access to our archive by becoming a member of Innovation Origins. Sign up here as a supporter of independent journalism!

Become a member!

On Innovation Origins you can read the latest news about the world of innovation every day. We want to keep it that way, but we can't do it alone! Are you enjoying our articles and would you like to support independent journalism? Become a member and read our stories guaranteed ad-free.

About the author

Author profile picture Bart Brouwers is co-founder and co-owner of Media52 BV, the publisher of innovationorigins.com.